Biotech By Adam Feuerstein Vindicated. New J&J CAR-T myeloma data confirm strong efficacy, ease doubts raised by Chinese version
Biotech By Adam Feuerstein Divergent results from Agios, Forma trials for their sickle cell disease drugs
Biotech By Matthew Herper With new data and a storied history, Eli Lilly’s blood cancer pill is looking stronger
Biotech By Adam Feuerstein Constellation’s blood cancer drug shows greater benefit, easing concerns about its future
Biotech By Adam Feuerstein J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity
Biotech By Adam Feuerstein Genetically targeted drug from Kura Oncology induces remissions in adult leukemia patients
Biotech By Adam Feuerstein Preliminary but ‘nothing short of great.’ New data on CRISPR treatment for blood diseases suggest cure is possible
Biotech By Adam Feuerstein Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’